Voyant’s Smart Toilet Platform Addresses $13B Potential Market as it Simplifies Urine Sample Collection and Testing

Going to the doctor is not always a preferred activity, and part of that is the testing involved, including, of course, the ubiquitous urine test. This remains a standard method used to determine the proper course of treatment for patients and to prevent exposure to potentially harmful medications and procedures. Point-of-care urine tests are used to diagnose a range of conditions,

Q&A with Fletcher Wilson, Founder and CEO of InterVene

Entrepreneurship runs in Fletcher Wilson’s veins – quite literally. As founder and CEO of InterVene, a Fogarty Institute graduate that has developed a minimally invasive device for the treatment of severe venous disease in the legs, Fletcher has many of the traits that make a successful leader and innovator. That includes a penchant for identifying problems and finding solutions,

Spotlight: Eric Chehab, Ph.D., Ferolyn Fellow

Seemingly intractable issues often have simple, elegant solutions when approached with creativity. That’s what Eric Chehab, Ph.D., has found in his work designing products that solve problems in neonatal care.

As the newest addition to the Ferolyn Fellowship class, he has already attained notable accomplishments in his young career, including co-founding and spearheading Novonate.

Q&A with Mike Mussallem, Chairman and CEO of Edwards Lifesciences

Edwards Lifesciences’ first and only chairman and CEO, Mike Mussallem, is the leading force behind the company’s success and committed culture of giving back to global communities.

Widely recognized as being at the forefront of patient-focused medical innovations for structural heart disease and critical care monitoring, the company has seen its value jump 4,000 percent and employment double to more than 13,000 in the past 18 years,

Raydiant Oximetry Raises Series A Funding; Graduates from Fogarty Institute

Raydiant Oximetry, a Fogarty Institute company that is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth, has closed a $5.6 million Series A funding round led by VCapital. It follows on the heels of a recent string of funding rounds, grants and an exit by fellow Fogarty companies Enspectra

EchoPixel Launches Intraoperative Device; Targets Structural Heart Disease

EchoPixel’s revolutionary technology is rapidly gaining adoption, having already been implemented by over 20 percent of the congenital heart defect programs in the U.S. and used extensively in complex, life-saving surgeries. It has played an essential role in several high-profile cases and has proven successful in both open surgery and interventional procedures.

Spotlight: Maria Artunduaga, MD, MPH, MTM, Ferolyn Fellow

When her beloved grandmother died from chronic obstructive pulmonary disease (COPD), a progressive lung condition that obstructs breathing, Maria Artunduaga, MD, MPH, MTM, realized it was an area that needed attention. That incident became a turning point in her training, leading her to the next phase of what has already been a highly accomplished career.

START TYPING AND PRESS ENTER TO SEARCH